Tenofovir vs Entecavir Among Patients With HBV-Related HCC After Resection

IMPORTANCE: Tenofovir disoproxil and entecavir are both commonly used first-line antiviral treatments, but their comparative recurrence and overall survival (OS) benefits remain unclear. OBJECTIVE: To explore differences of tenofovir disoproxil vs entecavir in recurrence-free survival (RFS) and OS a...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Pengpeng, Wang, Yuanyuan, Yu, Jian, Yu, Judian, Tao, Qifei, Zhang, Jinwei, Lau, Wan Yee, Zhou, Weiping, Huang, Gang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Medical Association 2023
Materias:
Original Investigation
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10618847/
https://www.ncbi.nlm.nih.gov/pubmed/37906195
http://dx.doi.org/10.1001/jamanetworkopen.2023.40353

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10618847/
https://www.ncbi.nlm.nih.gov/pubmed/37906195
http://dx.doi.org/10.1001/jamanetworkopen.2023.40353

Ejemplares similares